These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transfusion of blood products in trauma: an update. Fraga GP; Bansal V; Coimbra R J Emerg Med; 2010 Aug; 39(2):253-60. PubMed ID: 19345046 [TBL] [Abstract][Full Text] [Related]
3. Reduction in plasma transfusion after enforcement of transfusion guidelines. Tavares M; DiQuattro P; Nolette N; Conti G; Sweeney J Transfusion; 2011 Apr; 51(4):754-61. PubMed ID: 20946197 [TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives"]. Welte M Anaesthesist; 2009 Nov; 58(11):1150-8. PubMed ID: 19838643 [TBL] [Abstract][Full Text] [Related]
5. Appropriateness of Plasma Transfusion: A College of American Pathologists Q-Probes Study of Guidelines, Waste, and Serious Adverse Events. Alcorn K; Ramsey G; Souers R; Lehman CM Arch Pathol Lab Med; 2017 Mar; 141(3):396-401. PubMed ID: 28234567 [TBL] [Abstract][Full Text] [Related]
6. Increasing compliance with institutional guidelines for fresh-frozen plasma transfusions. Holland LL; Brooks JP Transfusion; 2007 Nov; 47(11):2169-70; author reply 2170. PubMed ID: 17958547 [No Abstract] [Full Text] [Related]
7. Transfusion audit of fresh-frozen plasma in southern Taiwan. Yeh CJ; Wu CF; Hsu WT; Hsieh LL; Lin SF; Liu TC Vox Sang; 2006 Oct; 91(3):270-4. PubMed ID: 16958841 [TBL] [Abstract][Full Text] [Related]
8. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy]. Heim MU Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420 [TBL] [Abstract][Full Text] [Related]
9. Current transfusion therapy: indications for basic components. Williams EF Clin Lab Sci; 1994; 7(4):219-24. PubMed ID: 10147431 [TBL] [Abstract][Full Text] [Related]
10. A role for prospective monitoring of plasma transfusion. Sachais B Transfusion; 2011 Apr; 51(4):674-5. PubMed ID: 21496038 [No Abstract] [Full Text] [Related]
12. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. O'Mahony B; Turner A Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632 [No Abstract] [Full Text] [Related]
13. [Safety of plasma products may be improved]. Wahlberg T Lakartidningen; 1995 Dec; 92(51-52):4869-70. PubMed ID: 8544500 [No Abstract] [Full Text] [Related]
14. [Quality assurance management system for therapy with blood and blood products]. Diekamp U Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053 [No Abstract] [Full Text] [Related]
15. [Indications for labile blood products]. Jeanne M; Rasonglès P Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505 [TBL] [Abstract][Full Text] [Related]
16. [Techniques of preparation and indications of labile blood products]. Clément S Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355 [TBL] [Abstract][Full Text] [Related]
17. [Evolution of indications and consumptions of fresh frozen plasma from 1997 to 2003 in a teaching Hospital]. Boulat C; Clero B Transfus Clin Biol; 2005 Jul; 12(3):251-6. PubMed ID: 15953748 [TBL] [Abstract][Full Text] [Related]
18. [Blood transfusion and blood-derived products transfusion. Immunologic principles and indications]. Lamy B; Morel P; Hervé P Rev Prat; 1998 Mar; 48(5):549-53. PubMed ID: 9781121 [No Abstract] [Full Text] [Related]
19. Transfusion medicine and surgical practice. Valeri CR Bull Am Coll Surg; 1993 Sep; 78(9):19-24. PubMed ID: 10171511 [TBL] [Abstract][Full Text] [Related]
20. [Transfusion of homologous red cells: products, indications and alternatives]. Therapie; 2004; 59(3):349-73. PubMed ID: 15559188 [No Abstract] [Full Text] [Related] [Next] [New Search]